Zhejiang Fangge Pharmaceutical

Zhejiang Fangge Pharmaceutical is a specialized pharmaceutical company focused on the research, development, and manufacturing of medicinal mushroom extracts and fungal-based therapeutics. Headquartered in Qingyuan, China, the company utilizes advanced extraction and purification technologies to produce standardized polysaccharides from species such as Maitake, Reishi, and Shiitake. Their products are primarily utilized as adjuvant therapies in oncology, as well as for treating chronic hepatitis and boosting immune function. The company operates GMP-certified facilities and is a leading supplier of fungal active pharmaceutical ingredients (APIs) and finished health products to global markets. Their commitment to mycological science has established them as a key player in the integration of traditional fungal medicine with modern pharmacological standards. The company's strategic location in the Mushroom City of China ensures a stable supply of high-quality raw materials for their extensive product line.